Shares have slumped more than 33% in 2025, far underperforming the broader market. The S&P 500 is down roughly 2% so far this year.
Bitcoin to stay under pressure in the near term, JPMorgan warns
JPMorgan doesn’t expect a big move higher in crypto in the near future.
Low-beta growth stocks to ride out the Trump roller coaster, according to Trivariate Research
Buying low-beta stocks such as Mastercard and Boston Scientific could help improve portfolio performance, Trivariate Research said.
Retail traders are really confused about what to do during the market sell-off this week
Individual traders don’t know what to do right now.
Here are Thursday’s biggest analyst calls of the day: Nvidia, Marvell, Apple, Tesla, Amazon, Robinhood & more
Here are Thursday’s biggest calls on Wall Street.
Wells Fargo downgrades MongoDB after earnings, says stock is rangebound from here
MongoDB issued weaker-than-expected full year guidance because of slow growth in its Atlas cloud-based database service.
Marvell Technology’s post-earnings sell-off is a buying opportunity, Loop Capital says in upgrade
The disappointed response — Marvell shares are down 16% in the premarket — is one investors should take advantage of, the firm said.
This insulin delivery system stock at the ‘forefront of innovation’ can jump 25%, RBC says
The differentiated patch automated insulin delivery product from this company gives it a first mover advantage.
Evercore ISI names Amazon a top pick, says AI will boost the stock going forward
Investors are underestimating the boost artificial intelligence will give to Amazon, according to Evercore ISI.
Thursday’s big stock stories: What’s likely to move the market in the next trading session
Stocks popped on Wednesday as investors hoped for concessions to Trump’s tariffs. Here’s what’s on CNBC’s radar heading into Thursday.